CVS HEALTH CORP (CVS) Stock Institutional Trading Activity


CVS HEALTH CORP (CVS) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Hancock Classic Value, Ariel Appreciation Fund, Olstein Capital Management, Cullen Value Fund, and Tweedy, Browne Co All Funds (US). Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2025Dodge & Cox Stock FundBuy3,353,22373,459,122$4,976,855,516
Q1 2025Olstein Capital ManagementSell-13,000110,000$7,453
Q1 2025Matrix Private Capital GroupSell-3546,868$465,307
Q1 2025Sequoia Financial AdvisorsBuy3,74844,905$3,042,342
Q1 2025Renaissance Technologies LLCSell-917,15350,000$3,387,500
Q1 2025Hillman Value FundSell-19,186100,450$6,805,488
Q1 2025Ariel Appreciation FundBuy91,4071,020,033$69,107,236
Q1 2025Turtle Creek Asset ManagementSell-254,5501,698,441$115,069,378
Q1 2025Hancock Classic ValueSell-1,928,20517,682,374$1,197,980,839
Q1 2025Cullen Value FundSell-2,95816,597$1,124,449
Q4 2024Dodge & Cox Stock FundBuy7,075,20970,105,899$3,147,053,806
Q4 2024Olstein Capital ManagementSell-42,000123,000$5,521
Q4 2024Matrix Advisors Value FundSell-9866,175$277,196
Q4 2024Matrix Private Capital GroupSell-4,5187,222$324,211
Q4 2024Sequoia Financial AdvisorsSell-6,55141,157$1,847,534
Q4 2024Hillman Value FundSell-1,891119,636$5,370,460
Q4 2024Ariel Appreciation FundBuy311,819928,626$41,686,021
Q4 2024Turtle Creek Asset ManagementSell-144,6761,952,991$87,669,766
Q4 2024Fairfax Financial HoldingsBuy2,697,0002,712,000$121,741,680
Q4 2024Hancock Classic ValueBuy6,475,27119,610,579$880,318,891
Q4 2024Cullen Value FundSell-10,61919,555$877,822
Q3 2024Dodge & Cox Stock FundBuy1,347,34763,030,690$3,963,369,787
Q3 2024Olstein Capital ManagementBuy10,000165,000$10,375
Q3 2024Matrix Advisors Value FundSell-11,4007,161$450,284
Q3 2024Matrix Private Capital GroupSell-1,37311,740$738,232
Q3 2024Sequoia Financial AdvisorsBuy15,74147,708$2,999,860
Q3 2024Hillman Value FundSell-2,802121,527$7,641,618
Q3 2024Ariel Appreciation FundSell-52,277616,807$38,784,824
Q3 2024Renaissance Technologies LLCBuy338,800967,153$60,814,581
Q3 2024Third PointBuy1,575,0001,575,000$99,036,000

Frequently asked questions about CVS activity

  • Which institutional owners are buying CVS?

    Institutional owners buying CVS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in CVS activity?

    "Buy" means an investor increased their reported position in CVS compared to the prior reporting period. This reflects growing exposure to CVS HEALTH CORP (CVS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in CVS increasing?

    Institutional interest in CVS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.